resveratrol has been researched along with verlukast in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Decendit, A; Ennamany, R; Henry, C; Krisa, S; Mérillon, JM; Vitrac, X | 1 |
| Artur, Y; Chagnon, MC; Delmas, D; Hanet, N; Heydel, JM; Jannin, B; Lançon, A; Latruffe, N; Lizard, G | 1 |
2 other study(ies) available for resveratrol and verlukast
| Article | Year |
|---|---|
Cellular uptake and efflux of trans-piceid and its aglycone trans-resveratrol on the apical membrane of human intestinal Caco-2 cells.
Topics: Biological Transport; Caco-2 Cells; Cell Membrane; Glucosides; Humans; Intestinal Mucosa; Kinetics; Membrane Glycoproteins; Membrane Transport Modulators; Membrane Transport Proteins; Monosaccharide Transport Proteins; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Propionates; Quinolines; Resveratrol; Sodium-Glucose Transporter 1; Stilbenes | 2005 |
Resveratrol in human hepatoma HepG2 cells: metabolism and inducibility of detoxifying enzymes.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Cell Line, Tumor; Chromatography, High Pressure Liquid; Enzyme Induction; Enzymes; Flow Cytometry; Glucuronosyltransferase; Humans; Liver Neoplasms; Mass Spectrometry; Metabolic Detoxication, Phase II; Multidrug Resistance-Associated Proteins; Propionates; Quinolines; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stilbenes; Sulfotransferases; Time Factors; Tritium | 2007 |